These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32978219)

  • 1. External contamination of antineoplastic drug vials: an occupational risk to consider.
    Cotteret C; Secretan PH; Gilles-Afchain L; Rousseau J; Vidal F; Salguero-Hernandez G; Batista J; Valverde V; Guitton J; Cisternino S; Schlatter J
    Eur J Hosp Pharm; 2022 Sep; 29(5):284-286. PubMed ID: 32978219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot study: External surface contamination of gemcitabine and 5-fluorouracil on drug packaging.
    Kåredal M; Özdemir J; Tinnert A; Wetterling M; Hedmer M
    J Oncol Pharm Pract; 2024 Jan; 30(1):9-14. PubMed ID: 36916178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss market.
    Fleury-Souverain S; Nussbaumer S; Mattiuzzo M; Bonnabry P
    J Oncol Pharm Pract; 2014 Apr; 20(2):100-11. PubMed ID: 23676511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual contamination in antineoplastic drug packaging.
    E Silva LS; Machado CDSB; Linden R; Antunes MV; da Silva LC; Wayhs CAY; Capp E; Ness SLR
    J Oncol Pharm Pract; 2023 Dec; 29(8):1862-1867. PubMed ID: 36659825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External contamination of antineoplastic drug containers from a Canadian wholesaler.
    Hilliquin D; Bussières JF
    J Oncol Pharm Pract; 2020 Mar; 26(2):423-427. PubMed ID: 31446868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy.
    Mason HJ; Morton J; Garfitt SJ; Iqbal S; Jones K
    Ann Occup Hyg; 2003 Nov; 47(8):681-5. PubMed ID: 14602675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden.
    Hedmer M; Georgiadi A; Bremberg ER; Jönsson BA; Eksborg S
    Ann Occup Hyg; 2005 Oct; 49(7):629-37. PubMed ID: 16126760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of external contamination on the vial surfaces of some hazardous drugs that commonly used in Chinese hospitals and comparison between environmental contamination generated during robotic compounding by IV: Dispensing robot vs. manual compounding in biological safety cabinet.
    Ml H; T W; Jq Z; Yj S; Tj G; Lk Z; J L; Jf Y
    J Oncol Pharm Pract; 2022 Oct; 28(7):1487-1498. PubMed ID: 34162245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators.
    Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D
    Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of contamination levels on the exterior surfaces of vials containing platinum anticancer drugs in Japan.
    Naito T; Osawa T; Suzuki N; Goto T; Takada A; Nakamichi H; Onuki Y; Imai K; Nakanishi K; Kawakami J
    Biol Pharm Bull; 2012; 35(11):2043-9. PubMed ID: 23123474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface contamination of hazardous drug pharmacy storage bins and pharmacy distributor shipping containers.
    Redic KA; Fang K; Christen C; Chaffee BW
    J Oncol Pharm Pract; 2018 Mar; 24(2):91-97. PubMed ID: 27856922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External contamination of commercial containers by antineoplastic agents: a literature review.
    Hilliquin D; Tanguay C; Bussières JF
    Eur J Hosp Pharm; 2020 Sep; 27(5):313-314. PubMed ID: 32839267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide contamination observed on the external surfaces of drug vials and the efficacy of cleaning on vial contamination.
    Touzin K; Bussières JF; Langlois E; Lefebvre M; Gallant C
    Ann Occup Hyg; 2008 Nov; 52(8):765-71. PubMed ID: 18663228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers.
    Sessink PJ; Boer KA; Scheefhals AP; Anzion RB; Bos RP
    Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verification of surface contamination of Japanese cyclophosphamide vials and an example of exposure by handling.
    Hama K; Fukushima K; Hirabatake M; Hashida T; Kataoka K
    J Oncol Pharm Pract; 2012 Jun; 18(2):201-6. PubMed ID: 21947739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective.
    Schulz H; Bigelow S; Dobish R; Chambers CR
    J Oncol Pharm Pract; 2005 Sep; 11(3):101-9. PubMed ID: 16390598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs.
    Ursini CL; Cavallo D; Colombi A; Giglio M; Marinaccio A; Iavicoli S
    Int Arch Occup Environ Health; 2006 Nov; 80(2):134-40. PubMed ID: 16761155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.
    Sessink PJ; Connor TH; Jorgenson JA; Tyler TG
    J Oncol Pharm Pract; 2011 Mar; 17(1):39-48. PubMed ID: 20156932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.
    Siderov J; Kirsa S; McLauchlan R
    J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.